The risk of malignancy and its incidence in early rheumatoid arthritis patients treated with biologic DMARDs

Treatment with disease-modifying anti-rheumatic drugs (DMARDs) has raised concerns about the risk of malignancies in rheumatoid arthritis (RA) patients. However, the association between biologic DMARDs (bDMARD...
Source: Arthritis Research and Therapy - Category: Rheumatology Authors: Tags: Research article Source Type: research